Search research articles
Contact Us
Filters
Showing results (51-60 of 210) with videos related to
Page
of 21
Sort By:
Cancer
|
January 14, 2020
Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status
Zoe H Fullerton, Santino S Butler, Brandon A Mahal, et al.
Cancer
|
June 1, 2019
Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer
Santino S Butler, Brandon A Mahal, Nayan Lamba, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 7, 1999
Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
R J Carter, L A Lione, T Humby, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 26, 2020
Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors
Shervin Tabrizi, Mohammed Alshalalfa, Brandon A Mahal, et al.
Journal of Geriatric Oncology
|
September 26, 2021
Association of race with receipt of definitive therapy for high risk prostate cancer in older men
Sagar A Patel, Yuan Liu, Brandon A Mahal, et al.
Cancer Genetics
|
March 4, 2022
DNA repair and immune checkpoint blockade response
Jimmy A Guo, Mohammed Alshalalfa, Daniel Y Kim, et al.
Journal of the National Cancer Institute
|
November 4, 2020
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation
Kevin H Kensler, Claire H Pernar, Brandon A Mahal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2000
Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation
K P Murphy, R J Carter, L A Lione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2015
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?
B A Mahal, M-H Chen, C L Bennett, et al.
Cancer Medicine
|
August 4, 2023
Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act
James R Janopaul-Naylor, Taylor J Corriher, Jeffrey Switchenko, et al.
Page
of 21
Search research articles
Search
Showing results (51-60 of 210) with videos related to
Sort By:
Page
of 21
Cancer
|
January 14, 2020
Short-term mortality risks among patients with oropharynx cancer by human papillomavirus status
Zoe H Fullerton, Santino S Butler, Brandon A Mahal, et al.
Cancer
|
June 1, 2019
Use and early mortality outcomes of active surveillance in patients with intermediate-risk prostate cancer
Santino S Butler, Brandon A Mahal, Nayan Lamba, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 7, 1999
Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation
R J Carter, L A Lione, T Humby, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 26, 2020
Doublecortin Expression in Prostate Adenocarcinoma and Neuroendocrine Tumors
Shervin Tabrizi, Mohammed Alshalalfa, Brandon A Mahal, et al.
Journal of Geriatric Oncology
|
September 26, 2021
Association of race with receipt of definitive therapy for high risk prostate cancer in older men
Sagar A Patel, Yuan Liu, Brandon A Mahal, et al.
Cancer Genetics
|
March 4, 2022
DNA repair and immune checkpoint blockade response
Jimmy A Guo, Mohammed Alshalalfa, Daniel Y Kim, et al.
Journal of the National Cancer Institute
|
November 4, 2020
Racial and Ethnic Variation in PSA Testing and Prostate Cancer Incidence Following the 2012 USPSTF Recommendation
Kevin H Kensler, Claire H Pernar, Brandon A Mahal, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
June 24, 2000
Abnormal synaptic plasticity and impaired spatial cognition in mice transgenic for exon 1 of the human Huntington's disease mutation
K P Murphy, R J Carter, L A Lione, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 1, 2015
High PSA anxiety and low health literacy skills: drivers of early use of salvage ADT among men with biochemically recurrent prostate cancer after radiotherapy?
B A Mahal, M-H Chen, C L Bennett, et al.
Cancer Medicine
|
August 4, 2023
Disparities in time to prostate cancer treatment initiation before and after the Affordable Care Act
James R Janopaul-Naylor, Taylor J Corriher, Jeffrey Switchenko, et al.
Page
of 21